Biomed Central Ltd

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. D'Angelo
    D'Angelo
  3. Devlin
    Devlin
  4. Famulare
    Famulare
  5. Lee
    Lee
  6. Pastore
    Pastore
  7. Paty
    Paty
  8. Robzyk
    Robzyk
  9. Schrag
    Schrag
  10. Stanchina
    Stanchina

Groups

  1. Department of Medicine (2)
  2. Hematologic Malignancies, Division of (2)
  3. Sloan Kettering Institute Postdocs (2)
  4. Adult Leukemia (1)
  5. Biostatistics Service (1)
  6. Center for Hematologic Malignancies (1)
  7. Colorectal Surgery (1)
  8. Department of Pathology and Laboratory Medicine (1)
  9. Epidemiology and Biostatistics (1)
  10. Pediatrics, Department of (1)
Search Within
  1. "Research letter"
Formats
  1. Research Letter (7)
Groups
  1. Department of Medicine (2)
  2. Hematologic Malignancies, Division of (2)
  3. Sloan Kettering Institute Postdocs (2)
  4. Adult Leukemia (1)
  5. Biostatistics Service (1)
  6. Center for Hematologic Malignancies (1)

More Groups

People
  1. Alessandro Pastore (1)
  2. Christopher Famulare (1)
  3. Deborah Schrag (1)
  4. Eytan Stein (1)
  5. Jaap Jan Boelens (1)
  6. Justin Taylor (1)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
Publications
  1. Journal of Hematology & Oncology (3)
  2. Molecular Cancer (2)
  3. Orphanet Journal of Rare Diseases (1)
  4. Trials (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Charting the metabolic biogeography of the colorectum in cancer: Challenging the right sided versus left sided classification
    Research Letter

    Jain, A.; Morris, M. T.; Berardi, D.; Arora, T.; Domingo-Almenara, X.; Paty, P. B.; Rattray, N. J. W.; Kerekes, D.; Lu, L.; Khan, S. A.; more...
    Molecular Cancer (2024)

    Fulltext@MSK | Save
  • Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
    Research Letter

    Frere, C.; Farge, D.; Schrag, D.; Prata, P. H.; Connors, J. M.
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Public access to protocols of contemporary cancer randomized clinical trials
    Research Letter

    Babu, C.; Mell, L.; Lee, N.; Zakeri, K.
    Trials (2021)

    Fulltext@MSK | Save
  • New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS)
    Research Letter

    Willemse, B. W. M.; van der Crabben, S. N.; Kerstjens-Frederikse, W. S.; Timens, W.; van Montfrans, J. M.; Lindemans, C. A.; Boelens, J. J.; Hennus, M. P.; van Haaften, G.
    Orphanet Journal of Rare Diseases (2021)

    Fulltext@MSK | Save
  • PD1/PD-L1 targeting in advanced soft-tissue sarcomas: A pooled analysis of phase II trials
    Research Letter

    Italiano, A.; Bellera, C.; D'Angelo, S.
    Journal of Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
    Research Letter

    Choi, S.; Wang, D.; Chen, X.; Tang, L. H.; Verma, A.; Chen, Z.; Kim, B. J.; Selesner, L.; Robzyk, K.; Zhang, G.; more...
    Molecular Cancer (2019)

    Fulltext@MSK | Save